249 related articles for article (PubMed ID: 28940538)
21. Regulation of steroid 5-alpha reductase type 2 (Srd5a2) by sterol regulatory element binding proteins and statin.
Seo YK; Zhu B; Jeon TI; Osborne TF
Exp Cell Res; 2009 Nov; 315(18):3133-9. PubMed ID: 19500568
[TBL] [Abstract][Full Text] [Related]
22. SRD5A2 gene polymorphisms and the risk of benign prostatic hyperplasia but not prostate cancer.
Choubey VK; Sankhwar SN; Carlus SJ; Singh AN; Dalela D; Thangaraj K; Rajender S
Asian Pac J Cancer Prev; 2015; 16(3):1033-6. PubMed ID: 25735326
[TBL] [Abstract][Full Text] [Related]
23. Upregulation of mir-1199-5p is associated with reduced type 2 5-α reductase expression in benign prostatic hyperplasia.
Liu Z; Lin Z; Cao F; Jiang M; Jin S; Cui Y; Niu YN
BMC Urol; 2022 Nov; 22(1):172. PubMed ID: 36344974
[TBL] [Abstract][Full Text] [Related]
24. Combination of Ligustri Lucidi Fructus with Ecliptae Herba and their phytoestrogen or phytoandrogen like active pharmaceutical ingredients alleviate oestrogen/testosterone-induced benign prostatic hyperplasia through regulating steroid 5-α-reductase.
Tao R; Liu E; Zhao X; Han L; Yu B; Mao H; Yang W; Gao X
Phytomedicine; 2022 Jul; 102():154169. PubMed ID: 35636178
[TBL] [Abstract][Full Text] [Related]
25. [5 alpha-reductase and prostate].
Lobaccaro JM; Boudon C; Lumbroso S; Lechevallier E; Mottet N; Rebillard X; Sultan C
Ann Endocrinol (Paris); 1997; 58(5):381-92. PubMed ID: 9685996
[TBL] [Abstract][Full Text] [Related]
26. Androgen regulation of 5α-reductase isoenzymes in prostate cancer: implications for prostate cancer prevention.
Li J; Ding Z; Wang Z; Lu JF; Maity SN; Navone NM; Logothetis CJ; Mills GB; Kim J
PLoS One; 2011; 6(12):e28840. PubMed ID: 22194926
[TBL] [Abstract][Full Text] [Related]
27. Inverse Regulation of DHT Synthesis Enzymes 5α-Reductase Types 1 and 2 by the Androgen Receptor in Prostate Cancer.
Audet-Walsh É; Yee T; Tam IS; Giguère V
Endocrinology; 2017 Apr; 158(4):1015-1021. PubMed ID: 28324044
[TBL] [Abstract][Full Text] [Related]
28. Expression of steroid 5α-reductase isozymes in prostate of adult rats after environmental stress.
Sánchez P; Torres JM; Castro B; Olmo A; del Moral RG; Ortega E
FEBS J; 2013 Jan; 280(1):93-101. PubMed ID: 23122426
[TBL] [Abstract][Full Text] [Related]
29. Association of polymorphisms within androgen receptor, 5alpha-reductase, and PSA genes with prostate volume, clinical parameters, and endocrine status in elderly men.
Schatzl G; Madersbacher S; Gsur A; Preyer M; Haidinger G; Haitel A; Vutuc C; Micksche M; Marberger M
Prostate; 2002 Jul; 52(2):130-8. PubMed ID: 12111704
[TBL] [Abstract][Full Text] [Related]
30. Androgen-induced prostate-specific antigen gene expression is mediated via dihydrotestosterone in LNCaP cells.
Zhu YS; Cai LQ; You X; Cordero JJ; Huang Y; Imperato-McGinley J
J Androl; 2003; 24(5):681-7. PubMed ID: 12954658
[TBL] [Abstract][Full Text] [Related]
31. Aromatase up-regulation, insulin and raised intracellular oestrogens in men, induce adiposity, metabolic syndrome and prostate disease, via aberrant ER-α and GPER signalling.
Williams G
Mol Cell Endocrinol; 2012 Apr; 351(2):269-78. PubMed ID: 22233684
[TBL] [Abstract][Full Text] [Related]
32. Importance of 5α-reductase gene polymorphisms on circulating and intraprostatic androgens in prostate cancer.
Lévesque É; Laverdière I; Lacombe L; Caron P; Rouleau M; Turcotte V; Têtu B; Fradet Y; Guillemette C
Clin Cancer Res; 2014 Feb; 20(3):576-84. PubMed ID: 24277450
[TBL] [Abstract][Full Text] [Related]
33. Messenger ribonucleic acid levels of steroid 5 alpha-reductase 2 in human prostate predict the enzyme activity.
Söderström TG; Bjelfman C; Brekkan E; Ask B; Egevad L; Norlén BJ; Rane A
J Clin Endocrinol Metab; 2001 Feb; 86(2):855-8. PubMed ID: 11158057
[TBL] [Abstract][Full Text] [Related]
34. 5α-reduction of epitestosterone is catalysed by human SRD5A1 and SRD5A2 and increases androgen receptor transactivation.
Schiffer L; Arlt W; Storbeck KH
J Steroid Biochem Mol Biol; 2024 Jul; 241():106516. PubMed ID: 38582131
[TBL] [Abstract][Full Text] [Related]
35. Somatic mutations at the SRD5A2 locus encoding prostatic steroid 5alpha-reductase during prostate cancer progression.
Akalu A; Dlmajian DA; Highshaw RA; Nichols PW; Reichardt JK
J Urol; 1999 Apr; 161(4):1355-8. PubMed ID: 10081907
[TBL] [Abstract][Full Text] [Related]
36. 5alpha-reductase isozymes and aromatase are differentially expressed and active in the androgen-independent human prostate cancer cell lines DU145 and PC3.
Negri-Cesi P; Colciago A; Poletti A; Motta M
Prostate; 1999 Dec; 41(4):224-32. PubMed ID: 10544295
[TBL] [Abstract][Full Text] [Related]
37. Glucocorticoids are induced while dihydrotestosterone levels are suppressed in 5-alpha reductase inhibitor treated human benign prostate hyperplasia patients.
Jin R; Forbes C; Miller NL; Strand D; Case T; Cates JM; Kim HH; Wages P; Porter NA; Mantione KM; Burke S; Mohler JL; Matusik RJ
Prostate; 2022 Oct; 82(14):1378-1388. PubMed ID: 35821619
[TBL] [Abstract][Full Text] [Related]
38. NAD(P)H-quinone oxidoreductase 1 silencing aggravates hormone-induced prostatic hyperplasia in mice.
Kim HT; Kim YJ; Park SR; Ryu SY; Jung JY
Andrologia; 2018 Apr; 50(3):. PubMed ID: 29110315
[TBL] [Abstract][Full Text] [Related]
39. Oestrogen and benign prostatic hyperplasia: effects on stromal cell proliferation and local formation from androgen.
Ho CK; Nanda J; Chapman KE; Habib FK
J Endocrinol; 2008 Jun; 197(3):483-91. PubMed ID: 18492814
[TBL] [Abstract][Full Text] [Related]
40. [Genetic determinants of anatomical variants of the prostate].
Hamadeh H; Larré S; Azzouzi AR; Cancel-Tassin G; Vallancien G; Cochand-Priollet B; Cussenot O
Prog Urol; 2008 Apr; 18(4):214-22. PubMed ID: 18501301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
